Research Article | | Peer-Reviewed

In-Hospital Mortality of Acute Coronary Syndromes Undergoing Coronary Angiography: A Multicenter Study in Dakar, Senegal

Received: 1 April 2025     Accepted: 1 May 2025     Published: 14 May 2025
Views:       Downloads:
Abstract

Acute Coronary Syndrome (ACS) significantly contributes to cardiovascular mortality worldwide, with an increasing prevalence in Africa due to rising cardiovascular risk factors. Despite advances in reperfusion therapies like percutaneous coronary intervention (PCI), many African countries, including Senegal, face substantial barriers to optimal care. This study aimed to assess in-hospital mortality among ACS patients undergoing coronary angiography in Dakar, Senegal, and to describe clinical features associated with mortality. We conducted a retrospective, multicenter, cross-sectional study involving patients hospitalized with ACS who underwent coronary angiography between January 2020 and June 2023 in three tertiary cardiology centers in Dakar. Demographic data, clinical presentation, cardiovascular risk factors, angiographic findings, and therapeutic interventions were collected. Statistical analysis included descriptive statistics and bivariate comparisons, with significance defined at p<0.05. Out of 2573 ACS patients undergoing coronary angiography, 30 died, resulting in an in-hospital mortality rate of 1.16%. The mean age was 61.2 ± 10.8 years, predominantly male (76.7%). Hypertension (53.3%) and sedentary lifestyle (83.3%) were common risk factors. Most patients presented with atypical chest pain (76.7%) and delayed hospital admission beyond 12 hours (43.3%). STEMI accounted for 70% of cases, with the left anterior descending artery frequently involved (80%). PCI using drug-eluting stents was performed in 56.7% of deceased patients. Cardiogenic shock was the leading complication (46.7%). In-hospital mortality following coronary angiography for ACS in urban Senegal is relatively low but delayed presentations and atypical symptoms remain significant barriers. Enhanced public awareness, reduced delays to intervention, and overcoming socioeconomic obstacles are essential to improve outcomes.

Published in Cardiology and Cardiovascular Research (Volume 9, Issue 2)
DOI 10.11648/j.ccr.20250902.12
Page(s) 47-53
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Acute Coronary Syndrome, Percutaneous Coronary Intervention, In-hospital Mortality, Sub-Saharan Africa

1. Introduction
Acute Coronary Syndrome (ACS) represents the major manifestation and contributing factor to mortality in coronary artery disease (CAD). ACS is a growing health concern across Africa, with recent estimates reporting a prevalence ranging from 0.21% to 22% . There is a steady increase in CAD prevalence in Africa as a result of an increase in cardiovascular risk factors such as hypertension, obesity, diabetes, dyslipidemia, and cigarette smoking. Africa also faces challenges in diagnosis and management of CAD.
Although ACS-related mortality has gradually declined over the last decades in developed countries, the trend is completely different for developing countries. Minimizing time delays in diagnosis and reperfusion (preferably by percutaneous coronary intervention, PCI) for patients with ST-elevation myocardial infarction (STEMI) is recommended to reduce mortality. Despite these recommendations, up to 42% of patients with AMI in Africa do not receive any form of reperfusion. In many African countries, such as Senegal, there is a lack of coordination and integration among different levels of healthcare services, resulting in suboptimal care and a poor prognosis. In addition, there are few comprehensive epidemiological data on acute coronary syndromes in Senegal.
Given the recent development of Cath labs and percutaneous coronary intervention in Senegal, we aim to assess the in-hospital mortality rate in acute coronary syndrome (ACS) and describe the characteristics of deceased patients undergoing coronary angiography.
2. Methods
A retrospective cross-sectional study was conducted from January 1, 2020, to June 30, 2023, across three cardiology departments: General Idrissa Pouye Hospital (HOGIP), Dakar Principal Hospital (HPD), and the National University Hospital Center of FANN (CHNUF). The study included all deceased patients hospitalized for Acute Coronary Syndrome (ACS) and who underwent coronary angiography during this period. Patients with incomplete medical records and missing essential demographic, clinical, or angiographic data were excluded.
The data collected included:
1. Socio-demographic status: Age (recorded in years), sex, residence area (urban, suburban, or rural), professional status, educational level (primary, secondary, tertiary education, or none), and socioeconomic status (classified as low, medium, or high based on occupation, monthly income, and health coverage).
2. Clinical parameters: Chest pain characteristics (typical angina, atypical chest pain, or non-specific discomfort), time between symptom onset and hospital admission categorized as follow: ≤12 hours or >12 hours, Killip classification at admission (ranging from class I to IV), vital parameters, including heart rate (beats per minute) and blood pressure (mmHg), at admission.
3. Risk Factor and Medical History Variables: Self-reported tobacco use, hypertension, diabetes mellitus (fasting blood glucose ≥ 126 mg/dL or ongoing treatment), dyslipidemia, obesity (BMI ≥30 kg/m²), sedentary lifestyle, and family history of premature cardiovascular disease, prior ACS events, stroke, transient ischemic attack, and history of chronic kidney disease
4. Electrocardiographic findings: Documentation included the presence or absence of persistent ST-segment elevation (≥2 mm in men and ≥1.5 mm in women in at least two contiguous leads), the occurrence of pathological Q waves, ST depression, T-wave inversion, rhythm disturbances (atrial fibrillation, ventricular tachycardia, fibrillation), and conduction abnormalities.
5. Biological Variables: Included troponin levels (elevated or normal with quantification in ng/mL), creatine phosphokinase-MB (CPK-MB, IU/L), serum creatinine (mg/dL), lipid profile (LDL-C, HDL-C, triglycerides levels), inflammatory markers (CRP levels), renal function (glomerular filtration rate estimated by MDRD formula), and hemoglobin level
6. Echocardiographic parameters included left ventricular ejection fraction (LVEF) assessed by Simpson's biplane method, regional wall motion abnormalities (hypokinesia, akinesia, dyskinesia), valvular pathology, and the presence of pericardial effusion.
7. Coronary angiography data included arterial access (radial or femoral approach), identification of affected coronary arteries (left anterior descending artery, circumflex artery, right coronary artery), number and severity of lesions (classified as significant stenosis ≥50%), type of coronary lesions (single-vessel, two-vessel, or multi-vessel disease), and presence of thrombus or calcifications. Details regarding percutaneous coronary intervention (PCI) were specified, including types of stents used (drug-eluting, bare-metal stents), procedural success, and occurrence of peri-procedural complications.
8. Medications: Documented medical therapy included thrombolytics, dual antiplatelet therapy (aspirin, clopidogrel, ticagrelor), anticoagulants (unfractionated heparin, low molecular weight heparin), anti-ischemic medications (beta-blockers, nitrates, calcium channel blockers, inhibitors of the renin-angiotensin-aldosterone system), statins, analgesics (morphine), proton pump inhibitors, and oxygen therapy.
Statistical analysis was performed using SPSS software. Quantitative data were presented as means with standard deviations (mean ± SD), while qualitative variables were presented as frequencies and percentages. For analytical analysis, comparisons between groups used the Student's t-test or Mann-Whitney U test for continuous variables depending on data distribution. Qualitative variables were analyzed with the Chi-square test or Fisher’s exact test as appropriate. Statistical significance was set at a p-value <0.05.
3. Results
The study included 30 patients hospitalized for Acute Coronary Syndrome (ACS) who underwent coronary angiography and died across three cardiology departments. During this period, 2573 patients admitted for ACS underwent coronary angiography, resulting in an in-hospital mortality rate of 1.16% following coronary angiography. The mean age of the participants was 61.2 ± 10.8 years, and the majority were males (76.7%). A sedentary lifestyle (83.3%) and hypertension (53.3%) were the most prevalent cardiovascular risk factors. Most patients presented with atypical chest pain (76.7%) and were admitted more than 12 hours after symptom onset in 43.3% of cases. ST-elevation myocardial infarction (STEMI) was diagnosed in 70% of cases. Table 1 summarizes the characteristics of the patients.
Table 1. Characteristics of the Studied Population (N=30).

Characteristic

Percentage (%) or Mean ± SD

Sociodemographic Variables

Age (years)

61.4 ± 12.3

Male Gender

76.7%

Sedentary Lifestyle

83.3%

Cardiovascular Risk Factors

Hypertension

53.3%

Diabetes mellitus

46.7%

Dyslipidemia

20%

Active smoking

23.3%

Obesity

3.3%

Clinical Presentation

Typical chest pain

23.3%

Atypical chest pain

76.7%

Killip classification ≥ II

46.7%

Admission delay (>12 hours)

43.3%

Coronary Angiography Findings

Radial approach

76.7%

Femoral approach

23.3%

Left Anterior Descending artery lesions

80%

Right coronary artery lesions

53.3%

Multivessel coronary disease

60%

Interventional Procedures

Angioplasty performed

56.7%

Drug-eluting stent used

100%

Thrombolysis attempted

30%

Medications

Aspirin

86.7%

Clopidogrel

86.7%

Statins

86.7%

Beta-blockers

66.7%

ACE inhibitors/ARBs

63.3%

Low molecular weight heparin

83.3%

Outcomes

In-hospital mortality

1.16%

Length of hospital stay (days)

6.2 ± 4.7 days

The left anterior descending artery was the culprit artery in 80% of cases. Angioplasty was performed in 56.7% of patients with drug-eluting stents in all patients (100%). Cardiogenic shock was the most frequent complication (46.7%), as shown in Figure 1.
Figure 1. Distribution of complications among deceased patients.
Patients who had percutaneous intervention (PCI) were younger (59.2 ± 10.1 versus 63.8 ± 14.2, p-value 0.331), mostly admitted less than 12 hours after symptoms onset (76.9% versus 23.1%, p-value 0.072), and all had anterior localization of their STEMI, p-value 0.010 (Table 2).
Table 2. Comparison of patients according to their revascularization status.

Variables

Angioplasty (n=17)

No Angioplasty (n=13)

p-value

Age (years) Mean ± SD

59.2 ± 10.1

63.8 ± 14.2

0.331

Male gender n (%)

13 (76.5%)

10 (76.9%)

0.978

Cardiovascular risk factors

Hypertension n (%)

7 (50.0%)

7 (50.0%)

0.491

Diabetes mellitus n (%)

10 (71.4%)

4 (28.6%)

0.127

Smoking n (%)

4 (57.1%)

3 (42.9%)

0.660

Chest pain type

Typical n (%)

4 (57.1%)

3 (42.9%)

0.631

Atypical n (%)

13 (59.1%)

9 (40.9%)

0.631

Admission delay

≤12 hours n (%)

10 (76.9%)

3 (23.1%)

0.072

>12 hours n (%)

6 (42.9%)

8 (57.1%)

0.072

ACS Type

STEMI n (%)

13 (61.9%)

8 (38.1%)

0.204

NSTEMI n (%)

4 (30.8%)

5 (69.2%)

0.310

ECG territory

Inferior STEMI n (%)

2 (22.2%)

7 (77.8%)

0.018

Anterior STEMI n (%)

7 (100%)

0 (0%)

0.010

ECG territory

Left anterior descending artery n (%)

15 (62.5%)

9 (37.5%)

0.204

Right coronary artery n (%)

7 (43.8%)

9 (56.2%)

0.127

Triple-vessel disease n (%)

7 (43.8%)

9 (56.2%)

0.127

Complications during hospitalization

Cardiogenic shock n (%)

7 (50.0%)

7 (50.0%)

0.491

Heart failure n (%)

1 (33.3%)

2 (66.7%)

0.402

Laboratory parameters

Hemoglobin ≤10 g/dL n (%)

4 (57.1%)

3 (42.9%)

0.546

Glomerular filtration rate <60 ml/min n (%)

6 (60.0%)

4 (40.0%)

0.402

SD= standard deviation; NSTEMI= Non-ST-segment Elevation Myocardial Infarction; STEMI= ST-segment Elevation Myocardial Infarction.
4. Discussion
4.1. Key Findings
The present study revealed a relatively low in-hospital mortality rate (1.16 %) among patients hospitalized for acute coronary syndromes (ACS) undergoing coronarography. This is lower than reports from other parts of Africa, ranging from 6.1% - 25.4%. and tend to be quite similar to those observed in Western Europe (1.8% - 3.9%) and North America (1.8% - 5.5%). These lower rates may be attributed to timely access to advanced therapies, such as percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), as well as the use of evidence-based medications. In a recent systematic review, Adem et al. revealed an all-cause in-hospital mortality rate associated with ACS in Africa to be as high as 22%. Additionally, the death rate was slightly lower in patients treated in cardiac centers (14%) than in patients treated in referral hospitals (24%). Several studies have identified predictors of mortality in ACS patients in Sub-Saharan Africa, such as advanced age, high Killip class (≥2) at admission, impaired renal function, sustained ventricular tachycardia and heart failure, and left ventricular dysfunction. These factors highlight the need for early intervention and improved access to guideline-directed therapies in SSA.
Financial constraints and out-of-the-pocket payments remain significant barriers to timely access to coronary angiography and PCI in our region. In the current study, angioplasty was successfully performed in only 56.7% of deceased patients, all of whom received drug-eluting stents. Similarly, data from the Registry for Acute Coronary Events in Nigeria (RACE-Nigeria) showed that coronary angiography was performed in only 42.4% of cases, with an overall reperfusion rate (including thrombolysis, PCI, and CABG) of 42.8%. Reperfusion was notably higher among upper-class patients compared to those from middle- or lower-socioeconomic groups (65.9% versus 45.6%, P < 0.0001). These findings underscore the persistent disparity in access to PCI, primarily driven by high procedural costs and socioeconomic inequalities in our country.
The high rate of atypical chest pain (76.7%) in our study may have contributed to late admission (43.3%) of cases and poor prognosis. Comparing patients presenting with typical and atypical chest pain and dyspnea, El Menyar et al. found that patients with atypical chest pain were less likely to receive thrombolytic therapy and had a delayed door-to-needle time (99 vs 55 min; p < 0.001) and worse in-hospital outcomes (higher rates of heart failure, cardiogenic shock, stroke, and mortality). In fact, atypical chest pain was associated with a 2-fold risk of in-hospital mortality (95% CI 1.29—2.75) after adjustment for confounders. Thus, increasing awareness and improving recognition of atypical ACS presentations among both healthcare providers and patients is crucial to reduce diagnostic delays and enhance clinical outcomes.
4.2. Study Limitations
This study has several limitations that should be acknowledged. Firstly, due to its retrospective and observational design, there may be missing or incomplete clinical data, which could lead to information bias and limit the accuracy of the recorded variables. To mitigate the impact of missing data, we carefully reviewed patient records and excluded only those cases with critically incomplete essential data. Nonetheless, the potential influence of selection bias cannot be entirely ruled out. The small sample size also reduces statistical power and the ability to generalize findings broadly across the population. Moreover, since this study was conducted exclusively in urban tertiary centers, it did not capture data from rural regions, which may limit the generalizability of our findings to populations with limited access to specialized cardiac care. Additionally, detailed information on patient adherence to prescribed treatments, socioeconomic status, and precise data on the timing between symptom onset and intervention were not consistently available, which limited a thorough assessment of factors influencing patient outcomes.
4.3. Implications
Despite these limitations, the findings of this study provide critical insights relevant to clinical practice and healthcare policy in our region. The relatively low in-hospital mortality rate observed highlights the potential benefits associated with timely access to advanced coronary interventions and guideline-directed therapies. However, significant financial and socioeconomic barriers persist, preventing equitable access to these essential interventions. To improve patient outcomes, addressing the financial constraints related to coronary angiography and PCI should be prioritized by healthcare policymakers. Additionally, our findings emphasize the importance of improving public and healthcare provider awareness about atypical presentations of acute coronary syndromes, potentially facilitating earlier diagnosis and intervention.
This study was conducted exclusively in urban tertiary centers, and thus did not include patients from rural settings, who often have limited access to specialized cardiac services. Consequently, our results may not be fully representative of the broader patient population in Senegal or other Sub-Saharan African countries. Future research should prioritize prospective, multicenter studies with larger sample sizes that deliberately include patients from both urban and rural environments. Such studies would offer more comprehensive data, enhance generalizability, and reduce potential biases associated with selective patient recruitment. A prospective design would also allow systematic tracking of clinical outcomes and adherence to therapeutic guidelines, providing stronger evidence to guide clinical practices and healthcare policy decisions.
5. Conclusion
Our study highlights a relatively low in-hospital mortality rate among patients undergoing coronary angiography for acute coronary syndromes, comparable to rates observed in high-income regions, suggesting the potential impact of timely coronary interventions and evidence-based therapies. However, significant socioeconomic and financial barriers persist, limiting equitable access to optimal care and negatively impacting clinical outcomes. The high prevalence of atypical chest pain leading to delayed diagnosis underscores the urgent need for increased awareness and better recognition of atypical presentations among both healthcare providers and the community. Addressing these challenges through targeted policy interventions, improved healthcare infrastructure, and public education initiatives is critical to further reduce mortality and improve patient outcomes in our region.
Abbreviations

ACE

Angiotensin Conversion Enzyme

ACS

Acute Coronary Syndrome

AMI

Acute Myocardial Infarction

ARBs

Angiotensin Receptor Blockers

BMI

Body Mass Index

CABG

Coronary Artery Bypass Grafting

CAD

Coronary Artery Disease

CK-MB

Creatin Kinase-MB

CRP

C-reactive Protein

ECG

Electrocardiogramm

HDL-C

High Density Lipoprotein-C

IU

International Unit

IV

Intravenous

LDL-C

Low Density Lipoprotein-C

LVEF

Left Ventricular Ejection Fraction

MDRD

Modification of Diet in Renal Disease

NSTEMI

Non-ST Elevation Myocardial Infarction

PCI

Percutaneous Coronary Intervention

RACE-Nigeria

Registry for Acute Coronary Events in Nigeria

SD

Standard Deviation

SPSS

Statistical Package for the Social Sciences

SSA

Sub-Saharan Africa

STEMI

ST-elevation Myocardial Infarction

Authors Contributions
Ngone D. Gaye: Visualization, Writing - original draft
Aliou A. Ngaide: Conceptualization, Supervision, Validation, Writing - review & editing
Pierre-Adley Ngoulla: Data curation, Investigation
Joseph Mingou: Writing - review & editing
Momar Dioum: Writing - review & editing
Mouhamed C. Mboup: Writing - review & editing
Fatou Aw: Writing - review & editing
Alassane Mbaye: Writing - review & editing
Bamba Ndiaye: Writing - review & editing
Maboury Diaw: Writing - review & editing
Abdoul Kane: Writing - review & editing
Funding
The study did not receive any funding.
Conflicts of Interest
The authors declare no conflicts of interest.
References
[1] Yao H, Ekou A, Niamkey T, Gan SH, Kouamé I, Afassinou Y, et al. Acute Coronary Syndromes in Sub-Saharan Africa: A 10-Year Systematic Review. Journal of the American Heart Association. 2022 Jan 4; 11(1).
[2] Shehu MN, Adamu UG, Ojji DB, Ogah OS, Sani MU. The Pandemic of Coronary Artery Disease in the Sub-Saharan Africa: What Clinicians Need to Know. Curr Atheroscler Rep. 2023 Sep; 25(9): 571–8.
[3] Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016 Jul; 4(13): 256.
[4] De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction. Circulation. 2004 Mar 16; 109(10): 1223–5.
[5] Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. European Heart Journal. 2023 Oct 12; 44(38): 3720–826.
[6] Rao SV, O’Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025 Feb 27; CIR. 0000000000001309.
[7] Rao A, Kardouh Y, Darda S, Desai D, Devireddy L, Lalonde T, et al. Impact of the prehospital ECG on door‐to‐balloon time in ST elevation myocardial infarction. Cathet Cardio Intervent. 2010 Feb; 75(2): 174–8.
[8] Rathore SS, Curtis JP, Chen J, Wang Y, Nallamothu BK, Epstein AJ, et al. Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study. BMJ. 2009 May 19; 338(may19 1): b1807–b1807.
[9] McNamara RL, Wang Y, Herrin J, Curtis JP, Bradley EH, Magid DJ, et al. Effect of Door-to-Balloon Time on Mortality in Patients With ST-Segment Elevation Myocardial Infarction. JACC. 2006; 47(11): 2180–6.
[10] Moustaghfir A, Haddak M, Mechmeche R. Management of acute coronary syndromes in Maghreb countries: The ACCESS (ACute Coronary Events – a multinational Survey of current management Strategies) registry. Archives of Cardiovascular Diseases. 2012 Nov; 105(11): 566–77.
[11] Stassen W, Wallis L, Lambert C, Castren M, Kurland L. Percutaneous coronary intervention still not accessible for many South Africans. African Journal of Emergency Medicine. 2017 Sep 1; 7(3): 105–7.
[12] Cilliers JCD, Joubert L, Beyers B, Ngarande E, Herbst P, Doubell A, et al. The incidence and outcomes of high-risk acute coronary syndromes in Western Cape Province, South Africa: A prospective cohort study. S Afr Med J. 2023 Apr 12; 113(5): 25–9.
[13] Fanta K, Daba FB, Asefa ET, Melaku T, Chelkeba L, Fekadu G, et al. Management and 30-Day Mortality of Acute Coronary Syndrome in a Resource-Limited Setting: Insight From Ethiopia. A Prospective Cohort Study. Front Cardiovasc Med. 2021; 8: 707700.
[14] Varwani MH, Jeilan M, Ngunga M, Barasa A. Outcomes in patients with acute coronary syndrome in a referral hospital in sub-Saharan Africa. Cardiovasc J Afr. 2019 Feb 23; 30(1): 29–33.
[15] Bahiru E, Temu T, Gitura B, Farquhar C, Huffman MD, Bukachi F. Presentation, management and outcomes of acute coronary syndrome: a registry study from Kenyatta National Hospital in Nairobi, Kenya. Cardiovasc J Afr. 2018 Aug 23; 29(4): 225–30.
[16] Lim GB. Acute coronary syndromes: Reduced mortality from MI in Denmark, England, and Poland. Nat Rev Cardiol. 2012 Feb 21; 9(4): 186.
[17] Adem F, Abdi S, Amare F, Mohammed MA. In-hospital mortality from acute coronary syndrome in Africa: a systematic review and meta-analysis. SAGE Open Medicine. 2023 Jan 1; 11: 20503121221143646.
[18] Yao H, Ekou A, Hadéou A, N’Djessan JJ, Kouamé I, N’Guetta R. Medium and long-term follow-up after ST-segment elevation myocardial infarction in a sub-Saharan Africa population: a prospective cohort study. BMC Cardiovasc Disord. 2019 Dec; 19(1): 65.
[19] Yao H, Ekou A, Niamkey T, Touré C, Guenancia C, Kouamé I, et al. Prognostic value of admission hyperglycaemia in black Africans with acute coronary syndromes: a crosssectional study. CVJA. 2020 Dec 15; 31(6): 39–44.
[20] Ekou A, Kipenge R, Yao H, Ehouman E, Touré C, Vy L, et al. Thirty-day and one-year outcomes and predictors of mortality following acute myocardial infarction in Côte d’Ivoire: Data from the REACTIV survey. Archives of Cardiovascular Diseases. 2024 Jan; 117(1): S21–2.
[21] Isezuo S, Sani MU, Talle A, Johnson A, Adeoye AM, Ulgen MS, et al. Registry for Acute Coronary Events in Nigeria (RACE-Nigeria): Clinical Characterization, Management, and Outcome. J Am Heart Assoc. 2022 Jan 4; 11(1): e020244.
[22] El-Menyar A, Zubaid M, Sulaiman K, AlMahmeed W, Singh R, Alsheikh-Ali AA, et al. Atypical presentation of acute coronary syndrome: A significant independent predictor of in-hospital mortality. Journal of Cardiology. 2011 Mar 1; 57(2): 165–71.
Cite This Article
  • APA Style

    Gaye, N. D., Ngaide, A. A., Ngoulla, P., Mingou, J., Dioum, M., et al. (2025). In-Hospital Mortality of Acute Coronary Syndromes Undergoing Coronary Angiography: A Multicenter Study in Dakar, Senegal. Cardiology and Cardiovascular Research, 9(2), 47-53. https://doi.org/10.11648/j.ccr.20250902.12

    Copy | Download

    ACS Style

    Gaye, N. D.; Ngaide, A. A.; Ngoulla, P.; Mingou, J.; Dioum, M., et al. In-Hospital Mortality of Acute Coronary Syndromes Undergoing Coronary Angiography: A Multicenter Study in Dakar, Senegal. Cardiol. Cardiovasc. Res. 2025, 9(2), 47-53. doi: 10.11648/j.ccr.20250902.12

    Copy | Download

    AMA Style

    Gaye ND, Ngaide AA, Ngoulla P, Mingou J, Dioum M, et al. In-Hospital Mortality of Acute Coronary Syndromes Undergoing Coronary Angiography: A Multicenter Study in Dakar, Senegal. Cardiol Cardiovasc Res. 2025;9(2):47-53. doi: 10.11648/j.ccr.20250902.12

    Copy | Download

  • @article{10.11648/j.ccr.20250902.12,
      author = {Ngone Diaba Gaye and Aliou Alassane Ngaide and Pierre-Adley Ngoulla and Joseph Mingou and Momar Dioum and Mouhamed Chérif Mboup and Fatou Aw and Alassane Mbaye and Bamba Ndiaye and Maboury Diaw and Abdoul Kane},
      title = {In-Hospital Mortality of Acute Coronary Syndromes Undergoing Coronary Angiography: A Multicenter Study in Dakar, Senegal
    },
      journal = {Cardiology and Cardiovascular Research},
      volume = {9},
      number = {2},
      pages = {47-53},
      doi = {10.11648/j.ccr.20250902.12},
      url = {https://doi.org/10.11648/j.ccr.20250902.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20250902.12},
      abstract = {Acute Coronary Syndrome (ACS) significantly contributes to cardiovascular mortality worldwide, with an increasing prevalence in Africa due to rising cardiovascular risk factors. Despite advances in reperfusion therapies like percutaneous coronary intervention (PCI), many African countries, including Senegal, face substantial barriers to optimal care. This study aimed to assess in-hospital mortality among ACS patients undergoing coronary angiography in Dakar, Senegal, and to describe clinical features associated with mortality. We conducted a retrospective, multicenter, cross-sectional study involving patients hospitalized with ACS who underwent coronary angiography between January 2020 and June 2023 in three tertiary cardiology centers in Dakar. Demographic data, clinical presentation, cardiovascular risk factors, angiographic findings, and therapeutic interventions were collected. Statistical analysis included descriptive statistics and bivariate comparisons, with significance defined at p<0.05. Out of 2573 ACS patients undergoing coronary angiography, 30 died, resulting in an in-hospital mortality rate of 1.16%. The mean age was 61.2 ± 10.8 years, predominantly male (76.7%). Hypertension (53.3%) and sedentary lifestyle (83.3%) were common risk factors. Most patients presented with atypical chest pain (76.7%) and delayed hospital admission beyond 12 hours (43.3%). STEMI accounted for 70% of cases, with the left anterior descending artery frequently involved (80%). PCI using drug-eluting stents was performed in 56.7% of deceased patients. Cardiogenic shock was the leading complication (46.7%). In-hospital mortality following coronary angiography for ACS in urban Senegal is relatively low but delayed presentations and atypical symptoms remain significant barriers. Enhanced public awareness, reduced delays to intervention, and overcoming socioeconomic obstacles are essential to improve outcomes.
    },
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - In-Hospital Mortality of Acute Coronary Syndromes Undergoing Coronary Angiography: A Multicenter Study in Dakar, Senegal
    
    AU  - Ngone Diaba Gaye
    AU  - Aliou Alassane Ngaide
    AU  - Pierre-Adley Ngoulla
    AU  - Joseph Mingou
    AU  - Momar Dioum
    AU  - Mouhamed Chérif Mboup
    AU  - Fatou Aw
    AU  - Alassane Mbaye
    AU  - Bamba Ndiaye
    AU  - Maboury Diaw
    AU  - Abdoul Kane
    Y1  - 2025/05/14
    PY  - 2025
    N1  - https://doi.org/10.11648/j.ccr.20250902.12
    DO  - 10.11648/j.ccr.20250902.12
    T2  - Cardiology and Cardiovascular Research
    JF  - Cardiology and Cardiovascular Research
    JO  - Cardiology and Cardiovascular Research
    SP  - 47
    EP  - 53
    PB  - Science Publishing Group
    SN  - 2578-8914
    UR  - https://doi.org/10.11648/j.ccr.20250902.12
    AB  - Acute Coronary Syndrome (ACS) significantly contributes to cardiovascular mortality worldwide, with an increasing prevalence in Africa due to rising cardiovascular risk factors. Despite advances in reperfusion therapies like percutaneous coronary intervention (PCI), many African countries, including Senegal, face substantial barriers to optimal care. This study aimed to assess in-hospital mortality among ACS patients undergoing coronary angiography in Dakar, Senegal, and to describe clinical features associated with mortality. We conducted a retrospective, multicenter, cross-sectional study involving patients hospitalized with ACS who underwent coronary angiography between January 2020 and June 2023 in three tertiary cardiology centers in Dakar. Demographic data, clinical presentation, cardiovascular risk factors, angiographic findings, and therapeutic interventions were collected. Statistical analysis included descriptive statistics and bivariate comparisons, with significance defined at p<0.05. Out of 2573 ACS patients undergoing coronary angiography, 30 died, resulting in an in-hospital mortality rate of 1.16%. The mean age was 61.2 ± 10.8 years, predominantly male (76.7%). Hypertension (53.3%) and sedentary lifestyle (83.3%) were common risk factors. Most patients presented with atypical chest pain (76.7%) and delayed hospital admission beyond 12 hours (43.3%). STEMI accounted for 70% of cases, with the left anterior descending artery frequently involved (80%). PCI using drug-eluting stents was performed in 56.7% of deceased patients. Cardiogenic shock was the leading complication (46.7%). In-hospital mortality following coronary angiography for ACS in urban Senegal is relatively low but delayed presentations and atypical symptoms remain significant barriers. Enhanced public awareness, reduced delays to intervention, and overcoming socioeconomic obstacles are essential to improve outcomes.
    
    VL  - 9
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Ibra Mamadou Wane Medical Center, Department of Cardiology, Dakar, Senegal

  • Department of Cardiology, Dalal Jamm Hospital, Guediawaye, Senegal;Department of Internal Medicine and Specialties, Cheikh Anta Diop University of Dakar, Dakar, Senegal

  • Department of Cardiology, Idrissa Pouye General Hospital, Dakar, Senegal

  • Department of Cardiology, Dalal Jamm Hospital, Guediawaye, Senegal;Department of Internal Medicine and Specialties, Cheikh Anta Diop University of Dakar, Dakar, Senegal

  • Department of Internal Medicine and Specialties, Cheikh Anta Diop University of Dakar, Dakar, Senegal;Department of Cardiology, Idrissa Pouye General Hospital, Dakar, Senegal

  • Department of Cardiology, Main Hospital, Dakar, Senegal

  • Department of Internal Medicine and Specialties, Cheikh Anta Diop University of Dakar, Dakar, Senegal

  • Department of Internal Medicine and Specialties, Cheikh Anta Diop University of Dakar, Dakar, Senegal; Department of Cardiology, Idrissa Pouye General Hospital, Dakar, Senegal

  • Department of Internal Medicine and Specialties, Cheikh Anta Diop University of Dakar, Dakar, Senegal

  • Department of Internal Medicine and Specialties, Cheikh Anta Diop University of Dakar, Dakar, Senegal

  • Department of Cardiology, Dalal Jamm Hospital, Guediawaye, Senegal;Department of Internal Medicine and Specialties, Cheikh Anta Diop University of Dakar, Dakar, Senegal